This OncoCloud Virtual panel discussion spoke on the value of RWE to support regulatory decision-making and improve patient care.
Real-world evidence has emerged as a critical component in cancer research to drive treatment development. Take a deep dive with industry experts to learn how real-world data from Flatiron supported the label expansion of cetuximab, leading to improved patient care and a better patient experience.
Speakers:
Kathleen Maignan, NP, MSN Senior Clinical Director Flatiron Health
Johnetta Blakely, MD, MS, MMHC Executive Director of Health Economics Outcomes Research, Tennessee Oncology
Himani Aggarwal, MA, MPhil, PhD Senior Research Scientist, Eli Lilly
Charu Aggarwal, MD, MPH
Leslye M. Heisler Associate Professor for Lung Cancer Excellence, University of Pennsylvania
